
Two therapeutic drugs benefited mice with non-small cell lung cancer, potentially paving the way for clinical trials in humans.

Northwestern Medicine scientists have developed a wireless, self-powered, bioresorbable implant for programmed drug delivery, the details of which are published in PNAS.

Patients with advanced-stage melanoma who received immunotherapy both before and after surgery had longer event-free survival than patients who received immunotherapy only after surgery, according to a recent clinical trial published in the New England Journal of Medicine.

Combining a new hormone therapy drug with chemotherapy and another hormone therapy increased overall survival in patients with high-volume and both high-risk and low-risk metastatic hormone-sensitive prostate cancer, according to a post hoc analysis published in the Journal of Clinical Oncology.

Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.

Northwestern Medicine scientists have developed a new tool to predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas.

Patients with severe eczema who were treated with dupilumab experienced a reduction in symptoms and improved quality of life, according to a meta-analysis of several clinical trials published in JAMA Dermatology.

Patients with nonproliferative diabetic retinopathy who received early therapeutic intervention saw no improvement in visual acuity compared to patients given a placebo, according to a clinical trial published in JAMA.

Northwestern University scientists have developed a first-of-its-kind small, flexible, stretchable bandage that accelerates healing by delivering electrotherapy directly to the wound site.

Liver transplant recipients who met the criteria for frailty had comparatively worse quality of life after their transplant, according to a new multicenter study published in JAMA Surgery.
Notifications